Drug Type Synthetic peptide |
Synonyms VT 346, VT346 |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | CA | 22 Dec 2009 | |
Graft Rejection | Preclinical | CA | 22 Dec 2009 | |
Inflammatory Bowel Diseases | Preclinical | CA | 22 Dec 2009 | |
Rheumatoid Arthritis | Preclinical | CA | 22 Dec 2009 |